Sign Up
Login
Try for Free
Login
The RBANS (Repeatable Battery for the Assessment of Neuropsychological Status) is a roughly 30-minute neuropsychological screening battery: 12 subtests yield five index scores and a Total Scale score, with four parallel forms for retesting. Neuropsychologists, psychologists, and medical teams use it to screen and track cognition in dementia, stroke, and psychiatric care. This page covers how to write up RBANS results, with a fictional sample.
Neuropsychologists and clinical psychologists, with trained examiners administering under supervision; publisher qualification level B
Referring physicians, neurologists, and geriatricians, memory clinics, rehabilitation teams, psychiatry services, courts and payers, families
250 to 600 words for the RBANS section · administration about 30 minutes
Norm-referenced neuropsychological screening battery
Dementia and mild cognitive impairment workups, post-stroke and rehabilitation baselines, psychiatric cognition checks, serial tracking with alternate forms
Published by NCS Pearson (1998; RBANS Update 2012); described here for write-up purposes, no test content reproduced
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is a brief, individually administered neuropsychological battery published in 1998 by The Psychological Corporation, now NCS Pearson, and authored by Christopher Randolph. Twelve short subtests yield five index scores (Immediate Memory, Visuospatial/Constructional, Language, Attention, and Delayed Memory) plus a Total Scale score, each on a standard-score metric with a mean of 100 and a standard deviation of 15, standardized on a US census-matched adult sample. Administration takes about 25 to 30 minutes. Its defining feature is in the name: four parallel forms (A through D) exist so cognition can be retested without repeating identical items, with Form A carrying the primary norms and equating adjustments linking the other forms, including a Spanish adaptation. The current edition is the RBANS Update (2012), which extended the age range from the original 20 to 89 down to 12:0 through 89:11, added subtest-level norms, and updated the manual with adolescent data and a research review. Pearson states plainly that "The items presented to the client have not changed", so older stimulus materials remain usable, and no newer edition has been announced as of July 2026.
The load-bearing distinction for any write-up is that the RBANS is a screening instrument, not a comprehensive evaluation. Pearson positions it as a stand-alone "core" battery for detecting and characterizing dementia and as a "screen" battery when longer assessment is impractical, and the National Academy of Neuropsychology's education paper draws the line that governs interpretation: "cognitive screening tests should not be used as a replacement for comprehensive neuropsychological testing". The battery also contains no executive function, letter-fluency, or motor subtests, so a defensible RBANS section names those absent domains rather than letting a normal Total Scale imply a clean cognitive bill of health. In practice a RBANS write-up either stands alone as a screening summary that ends in a referral decision or sits inside a full neuropsychological report alongside comprehensive instruments such as the WAIS and the D-KEFS.
Neuropsychologists and clinical psychologists interpret the RBANS, and Pearson lists it at qualification level B in the US catalog, so appropriately trained clinicians in memory clinics, neurology and stroke rehabilitation services, geriatric medicine, psychiatry, and hospital consultation settings all produce RBANS write-ups. The publisher positions it two ways, and the write-up should say which one applied: a stand-alone "core" battery for detecting and characterizing dementia in older adults, or a "screen" battery when a comprehensive evaluation is impractical or premature. It earns its place in serial work: four parallel forms exist specifically so cognition can be rechecked without repeating identical items, which is why rehabilitation teams and memory clinics tracking change reach for it first. Upstream of it sit bedside tools documented in a mental status exam; downstream sits the comprehensive evaluation written up as a full neuropsychological report, often built around instruments like the WAIS with executive measures such as the D-KEFS covering what the RBANS by design does not. A RBANS section usually lives inside that larger report or stands alone as a brief screening summary that ends with a referral decision.
No statute, payer, or publisher mandates a RBANS results-section format. The structure below is the convention experienced clinicians converge on because it survives review: it names the edition, form, norms, and mode of administration, reports the five indexes individually before any total, treats change scores statistically, and states out loud what a 30-minute screen cannot do. Each section carries the pitfall that most often undermines it.
Measures and methods statement. Name the battery and edition (RBANS, 1998, or RBANS Update, 2012), the form administered (A, B, C, or D, or Spanish record form), the platform (paper, Q-interactive, or Q-global scoring), the mode (in person or telepractice), and the norm set used. One methods sentence carries all of it: which stimulus form, which norms, and why the RBANS fits the referral question. Pitfall: writing "the RBANS" with nothing else. Form, norms, and mode each change what a score means, and a reviewer who cannot reconstruct them cannot defend the numbers.
Behavioral observations and validity statement. Two or three sentences on arousal, engagement, sensory or motor barriers, and effort, closing with an explicit statement of how performance validity was assessed. If an embedded RBANS effort indicator was computed, interpret it with published false-positive rates for the population in view; in genuine dementia, a stand-alone performance validity measure is the safer anchor. Pitfall: a validity sentence that quietly applies an embedded effort cutoff to a memory-clinic patient. The literature on false positives in dementia is exactly what a savvy reviewer will cite back.
Index-by-index results. Report each of the five indexes by name (Immediate Memory, Visuospatial/Constructional, Language, Attention, Delayed Memory) with its standard score and percentile, in the same order every time. Subtest-level scores, normed since the 2012 Update, belong here only when they add interpretive value. Describe the profile shape in prose: memory-predominant, patchy and lesion-congruent, or diffusely low. Pitfall: burying a divergent index inside a reassuring average. If Delayed Memory sits far below the others, the write-up says so plainly.
Total Scale handling. Report the Total Scale score once, then interpret the indexes. When indexes diverge substantially, say whether the spread exceeds base-rate expectations in healthy adults rather than treating any scatter as pathology, and keep diagnostic weight off the composite. Pitfall: leading with a single Total Scale number. A composite built from divergent indexes describes no ability the patient actually has.
Serial comparison. For retest write-ups, name the interval, the alternate form used, and the change method: a reliable change index or standardized regression-based change estimate, not raw point differences. State whether observed change clears the reliable-change threshold, and remember that an absent practice effect can itself be informative in a memory clinic. Pitfall: calling a small raw gain "improvement" or a small raw drop "decline". Measurement error and practice effects both move scores; reliable-change statistics exist to keep those out of the conclusion.
Domains not assessed and limits. One short paragraph stating that the battery samples five domains in about 30 minutes and contains no executive function, letter-fluency, or motor subtests, so conclusions in those domains come from other measures or remain open. Add the screen-versus-assessment boundary: findings inform whether comprehensive neuropsychological assessment is warranted. Pitfall: silence about scope. A reader who assumes the RBANS covered executive function will over-read a normal Total Scale as a clean bill of cognitive health.
Impression and recommendations linkage. Tie the profile to the referral question and to collateral data: informant report, daily-function changes, medical history. Every recommendation traces to a documented finding, and the referral recommendation states what a comprehensive evaluation would add. Pitfall: a screening profile carrying a diagnosis on its own. The RBANS contributes data to a diagnostic process; it does not finish one.
RBANS RESULTS SECTION SKELETON (adapt; delete guidance in parentheses before signing) MEASURES AND METHODS Edition (RBANS 1998 / RBANS Update 2012) and form (A / B / C / D / Spanish): ____ Platform (paper / Q-interactive / Q-global scoring) and mode (in person / telepractice): ____ Norm set used and why the RBANS fits the referral question: ____ BEHAVIORAL OBSERVATIONS AND VALIDITY Arousal, engagement, sensory or motor barriers: ____ How performance validity was assessed (stand-alone measure preferred in dementia): ____ INDEX-BY-INDEX RESULTS (standard scores; report each index, then the total) Immediate Memory: ____ Visuospatial/Constructional: ____ Language: ____ Attention: ____ Delayed Memory: ____ Total Scale (interpret indexes first when they diverge): ____ Profile shape in prose (memory-predominant / patchy / diffuse): ____ SERIAL COMPARISON (retest write-ups only) Interval, alternate form used, and prior scores: ____ Reliable change or SRB result, not raw point difference: ____ DOMAINS NOT ASSESSED AND LIMITS (No executive function, letter-fluency, or motor subtests; screen, not a comprehensive assessment; state what remains open): ____ INTEGRATION WITH COLLATERAL AND FUNCTION Informant report, daily-function changes, medical history: ____ IMPRESSION AND RECOMMENDATIONS Impression tied to the referral question: ____ Recommendations linked to findings, including whether comprehensive neuropsychological assessment is warranted: ____ Clinician signature, credentials, date: ____
Free to use and share, no signup. The PDF includes a one-page cheat sheet with section-by-section pitfalls and a pre-sign checklist; the DOCX is the blank results-section skeleton, ready to adapt.
Scenario: a 74-year-old retired teacher referred by her primary care physician after an annual wellness visit flagged memory concerns that her husband confirmed. The RBANS was administered as a screening battery in a hospital memory clinic; this is the RBANS section of the resulting consultation note, condensed but structurally complete. All details are fictional.
Client: R.M., 74 · Referral: memory concerns raised at an annual wellness visit, referred by primary care · Evaluator: L. Chen, PhD, Licensed Psychologist · Testing date: 07/09/2026 · Report date: 07/14/2026
Measures and methods: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS Update, 2012), Form A, administered on paper in person and scored in Q-global against the test's standardization norms. The RBANS was selected as a brief screening battery to characterize the reported memory change and inform whether comprehensive neuropsychological evaluation is warranted; administration took about 30 minutes. A stand-alone performance validity measure was also administered.
Behavioral observations and validity: Mrs. M. arrived on time with her husband, wore her prescribed glasses and hearing aids, and engaged readily. She worked carefully, asked for one repetition of task instructions, and showed mild frustration when she could not recall list items, saying "they slip away". Performance on the stand-alone validity measure was acceptable, and observed engagement supported valid results. Embedded RBANS effort indicators were not used as validity anchors, given their documented false-positive rates in older adults with genuine memory impairment.
Results: Index standard scores have a mean of 100 and a standard deviation of 15. Scores below are reported index by index; the profile, not the composite, carries the interpretation.
| Index | Standard score | Percentile |
|---|---|---|
| Immediate Memory | 78 | 7 |
| Visuospatial/Constructional | 98 | 45 |
| Language | 96 | 39 |
| Attention | 88 | 21 |
| Delayed Memory | 75 | 5 |
| Total Scale | 84 | 14 |
The profile is memory-predominant. Both memory indexes sit well below expectations for age (Immediate Memory at the 7th percentile, Delayed Memory at the 5th), while Visuospatial/Constructional and Language performance falls in the middle of the distribution (45th and 39th percentiles) and Attention is modestly reduced (21st percentile). Free recall of learned material after a delay was the weakest performance of the session, and recognition prompts recovered little of it, an observation recorded here because it sharpens the referral question for comprehensive testing. The Total Scale score of 84 (14th percentile) is reported for completeness but is not the finding: with a 23-point spread between the highest and lowest indexes, the memory-specific pattern is what the composite would otherwise hide. Obtained scores carry measurement error, and confidence intervals accompany these scores in the full report.
Scope of this screen: The RBANS samples five cognitive domains in about 30 minutes and contains no executive function, letter-fluency, or motor subtests. Conclusions about those domains, and any diagnostic conclusion, are outside what this screening battery can establish on its own.
Collateral and function: Mr. M., interviewed separately as an independent historian, described about eighteen months of gradually increasing repetition of questions, misplaced household items, and new reliance on written lists, with Mrs. M. recently handing over the couple's bill paying. He described her mood as good and her daily self-care as unchanged.
Impression and plan: Screening results show a memory-predominant profile that is consistent with the concerns raised at the wellness visit and by the family, in the context of preserved visuospatial and language performance and intact daily self-care with emerging instrumental-task changes. These screening findings do not establish a diagnosis. Comprehensive neuropsychological evaluation is recommended to characterize the memory impairment, assess domains this screen does not cover, and support diagnostic and care planning with her physician; medical workup of contributing conditions will proceed in parallel per the referring practice's pathway. If serial screening is used to track change, an alternate RBANS form with reliable-change methods is recommended rather than repeating Form A and comparing raw scores.
This sample is fictional and for educational purposes. It does not describe a real client or record, and the scores are invented for illustration and correspond to no real person or record.
Writing these after every session? BastionGPT drafts complete notes from bullets, dictation, or a transcript.
Generate a note from bulletsKnow which rule you are writing under, because the RBANS sits at the junction of three US regimes. The Medicare Annual Wellness Visit is required by regulation (42 CFR 410.15) to include "Detection of any cognitive impairment", defined as assessment by direct observation with due consideration of patient and family report; no specific instrument is mandated, which is LAW leaving tool choice to the clinician. When impairment is detected, the cognitive assessment and care plan service (99483) is PAYER POLICY with teeth: CMS contractor guidance states that 99483 requires an independent historian, notes the service is permanently covered via telehealth, and expects it no more than about once every 180 days. Formal testing billed under 96132/96133 (with administration under 96136 through 96139) must be medically necessary, and the same contractor policy is blunt about the boundary: testing when no mental illness or disability is suspected "would be considered screening and would not be covered by Medicare", while brief screens used in isolation are not classifiable as psychological or neuropsychological testing at all. The same policy lists assessment of decision-making capacity as a covered indication, and here convention matters: RBANS results contribute data to capacity, driving, and independent-living questions, but those are clinical and legal judgments that no screening score decides. In Canada, outpatient neuropsychological assessment is typically accessed privately, through extended health benefits, or inside hospital programs, and specifics vary by province, which is CONVENTION rather than a published entitlement. In Australia, a search of the Medicare Benefits Schedule for "neuropsychological" returns no general item for standalone adult assessment (verified July 2026); public access runs through specialist consultations, Better Access arrangements, or the under-25 complex neurodevelopmental pathway, with most adult work hospital-based or private.
The methods statement is where RBANS write-ups earn or lose their defensibility, because "the RBANS" is not one thing. Name the edition (1998 original or 2012 Update), the form (A through D, or Spanish), the platform (paper, Q-interactive, or Q-global scoring), the mode, and the norm set. The Update's published change list added subtest-level norms and the adolescent extension without changing the items, so as of July 2026 the core index norms trace to the original standardization program, and alternatives exist that change the numbers: age- and education-corrected norms built from 718 community-dwelling older adults recruited in primary care (Duff and colleagues, 2003), clinical norms for schizophrenia from 575 US patients (Wilk and colleagues, 2004) and 174 British Columbia inpatients (Iverson, Brooks, and Haley, 2009), and published Australian normative data (Green and colleagues, 2008), so the report must say which yardstick was applied. Telepractice deserves its own sentence: Pearson's guidance states that "Telepractice is a deviation from the standardized administration" and that the normative data were collected in person, and the supporting evidence base, while positive, remains small (an early videoconference study supporting feasibility and reliability enrolled 18 older adults), so remote administration is documented as a deviation with clinical judgment stated. Purchase requires Pearson qualification level B in the US catalog; qualification to buy is not competence for every interpretive use, which remains a licensing and professional-standards matter. Retention and access rules follow the parent record: a RBANS section inside a neuropsychological report or psychological evaluation report inherits that report's obligations, including the raw-data and test-security handling those pages cover.
RBANS is a trademark of NCS Pearson, Inc. BastionGPT is not affiliated with, or endorsed by, the publisher. This page reproduces no test items, stimuli, norms, or scoring materials.
The published numbers behind these flags are striking. When researchers applied the embedded RBANS Effort Index to people with genuine impairment, 37% of nursing-home residents and 33% of patients with probable Alzheimer's disease scored past the suggested cutoffs, against 3% of cognitively intact older adults (Duff and colleagues, 2011), and a mixed-dementia study put overall Effort Index failure at 48%, with the newer Effort Scale failing 4% of Alzheimer's cases but 31% of non-Alzheimer's dementias (Burton and colleagues, 2015). One-year index stability in a community-dwelling elderly sample ran from .58 to .83 (Duff and colleagues, 2005). Numbers like these are why reviewers read RBANS sections skeptically. The BastionGPT Clinical Advisory Board sees the same errors most often in RBANS write-up reviews:
BastionGPT is specifically trained, tuned, and clinically tested on psychological and neuropsychological evaluation reports.
See how clinicians use it day to day on the AI therapy notes page.
Many BastionGPT users report saving more than 90 minutes per day on documentation.
HIPAA-compliant with a signed BAA on every plan. Your data is never used to train models. BastionGPT drafts, you review and sign.
The RBANS reports five index scores (Immediate Memory, Visuospatial/Constructional, Language, Attention, Delayed Memory) and a Total Scale score, each a standard score with a mean of 100 and a standard deviation of 15, so 100 sits at the middle of the distribution for the normative group, 85 falls about one standard deviation below it (roughly the 16th percentile), and 70 about two below (near the 2nd percentile). Subtest-level scores have their own norms since the 2012 Update. Keep the percentile next to the number, and if you use qualitative descriptor words, name the labeling convention and apply it consistently; a neuropsychology consensus on uniform score labels exists for exactly this reason (Guilmette and colleagues, 2020). No RBANS score is a diagnostic cutoff: cut-scores in the research literature are study- and population-specific, and no consensus diagnostic threshold exists.
No. The current edition is the RBANS Update, released in 2012 as a revision of the 1998 original, and no newer edition has been announced as of July 2026. The Update extended the age range downward from the original 20 to 89 to 12:0 through 89:11, added subtest-level norms, added equating studies for Forms C, D, and Spanish Form A, and updated the manual with adolescent data and a review of RBANS research. Pearson's support materials state that "The items presented to the client have not changed", which is why older stimulus books remain usable and why your methods statement should name the edition and norms rather than assuming the reader knows. If a client was tested years apart, the same items may have been scored against different norm sets, which belongs in any serial comparison.
Depth and repeatability. Bedside screens like the MoCA and MMSE take minutes and produce a single global result, usually recorded within a mental status exam. The RBANS takes about 30 minutes and produces five co-normed index scores plus a total, with four parallel forms built for retesting, so it can characterize a profile (memory-predominant versus diffuse, for example) that a single number cannot. Medicare contractor policy even draws the line administratively: brief screening measures used in isolation are not classified as psychological or neuropsychological testing. What the RBANS does not do is graduate out of the screening category: it omits executive function, letter fluency, and motor domains, and a diagnostic answer still requires comprehensive evaluation.
No. The National Academy of Neuropsychology's education paper is explicit that screening results do not substitute for comprehensive neuropsychological testing, and Pearson itself positions the RBANS as a "core" battery for detecting and characterizing dementia, which is a contribution to a diagnostic process rather than the process. The instrument discriminates well at the group level (in one Alzheimer's study every index separated patients from controls, with the memory indexes strongest), but a diagnosis of a neurocognitive disorder integrates history, informant report, daily function, medical workup, and usually fuller testing. The defensible write-up reports the profile, states the screen's limits, and routes the diagnostic question to a comprehensive evaluation documented in a neuropsychological report.
No rule names it. The Annual Wellness Visit regulation (42 CFR 410.15) requires "Detection of any cognitive impairment", defined as assessment by direct observation with consideration of patient and family report; that is LAW, and it mandates no instrument. If impairment is detected, the cognitive assessment and care plan service (99483) is PAYER POLICY: CMS contractor guidance (article A59036) states it requires an independent historian, is permanently covered via telehealth, and is expected no more than about every 180 days. Formal testing under 96132/96133 requires documented medical necessity, and testing done purely as screening is not covered. Choosing the RBANS to answer a detected concern is CONVENTION: defensible, common, and never mandated.
Statistically, never as raw point differences. The alternate forms exist to reduce item practice, but scores still move with measurement error and practice: one-year index stability ran from .58 to .83 in a community-dwelling elderly sample (Duff and colleagues, 2005), and a large meta-analysis quantifies practice effects across repeated neuropsychological testing generally (Calamia and colleagues, 2012). The write-up names the interval and the form used, then applies a reliable change index or standardized regression-based (SRB) change equation. Use the updated SRB equations published in 2020, which replaced earlier equations that had failed to generalize, and which were externally validated in amnestic mild cognitive impairment in 2022 (Hammers and colleagues). State whether the observed change clears the reliable-change threshold; that sentence is the finding.
It can be, with the deviation documented. Pearson's guidance document states that "Telepractice is a deviation from the standardized administration" and reminds examiners that the normative data were collected in person; its subtest-level equivalence table adds that more research is needed across ages and tasks. The peer-reviewed evidence is positive but small: an early videoconference study in adults over 55 supported feasibility and reliability of remote administration (Galusha-Glasscock and colleagues, 2016). The defensible write-up names the mode, describes any facilitation at the patient's site, and interprets scores with the deviation stated, exactly as the publisher's telepractice guidance recommends.
No, and in dementia they mislead badly if used alone. Researchers have derived several embedded indicators from RBANS performance: the Effort Index (Silverberg and colleagues, 2007), the Effort Scale (Novitski and colleagues, 2012), and the Performance Validity Index and CRIER (Paulson and colleagues, 2015). The false-positive problem is well documented: 37% of nursing-home residents and 33% of probable Alzheimer's patients exceeded Effort Index cutoffs against 3% of cognitively intact older adults (Duff and colleagues, 2011), and a mixed-dementia sample failed the Effort Index at 48% overall, with the Effort Scale failing 31% of non-Alzheimer's dementias (Burton and colleagues, 2015). Professional consensus expects validity to be addressed proactively in every evaluation, so the working standard is a stand-alone performance validity measure plus stated clinical judgment, with embedded indicators treated as context calibrated to the population, never as a verdict.
Yes. BastionGPT is trained and clinically tested on psychological and neuropsychological evaluation reports, the parent documents RBANS sections live inside. Paste a score summary (edition, form, index scores, observations) and it drafts the results narrative with the methods statement, percentile framing, and screen-not-diagnosis boundary in place for your review; it can also check a finished section for a Total Scale doing diagnostic work, raw retest differences presented as change, or a missing form and norms statement, and produce a plain-language summary for the family or referring provider. BastionGPT is HIPAA-compliant with a signed BAA on every plan, your data is never used to train models, and drafting from a score summary you paste means no protocol or item content ever needs to leave your records.
The instrument facts and compliance claims on this page trace to these sources, last verified July 2026:
Educational content, not legal or billing advice. Sample notes are fictional. Follow your organization's policies and your board, payer, and jurisdiction requirements.